A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
Status:
Completed
Trial end date:
2011-06-24
Target enrollment:
Participant gender:
Summary
This is a study of bimatoprost as initial, replacement, or adjunctive intraocular pressure
(IOP)-lowering therapy in patients with primary open angle glaucoma and ocular hypertension.